Desk›Healthcare› Fischer Medical Ventures Ltd
Fischer Medical Ventures Ltd
BSE 524743 · NSE FISCHER · ISIN INE771F01041 · Group B · Active
Healthcare › Healthcare › Healthcare Equipment & Supplies › Medical Equipment & Supplies
₹35.31
-2.22%
BSE close, 28 August 2026
₹2,311.09 cr
65.5 cr shares · Micro cap
₹874.82 cr
as published
-176.6× · 30.44×
EPS ₹-0.20 · BV ₹1.16
17.39 / -10.42
₹ cr, as filed
35
7 selected · 20%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -71.6% |
|---|---|
| Against 52-week low | +13.4% |
| Day change | -2.22% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹-0.20 |
|---|---|
| Price / earnings | -176.55× |
| Price / book | 30.44× |
| Book value — derived, price ÷ P/B | ₹1.16 |
| Return on equity | -16.43% |
| Operating margin | -137.12% |
| Net margin | -485.32% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- -17.24%
- ROE as published
- -16.43%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 0.72 | -3.50 | -0.05 | -137.12% | -485.32% |
| Mar-26 · Q | 4.11 | -8.98 | -0.14 | -206.11% | -218.65% |
| FY25-26 | 17.39 | -10.42 | -0.16 | -29.76% | -59.93% |
Quarter on quarter
- Revenue, quarter on quarter
- -82.5%
- Net profit, quarter on quarter
- +61.0%
- Operating margin, quarter on quarter
- +6,899 bps
Disclosure profile 35 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Press Release | 4 |
| Board Outcome | 1 |
| Resignation | 1 |
| Results | 1 |
| Selected sub-total | 7 |
| Procedural | |
| Allotment | 5 |
| SAST | 5 |
| AGM / EGM | 3 |
| General | 3 |
| Analyst / Investor Meet | 2 |
| Newspaper Publication | 2 |
| Outcome | 2 |
| Annual Report | 1 |
| BRSR | 1 |
| Board Meeting | 1 |
| Monitoring Agency | 1 |
| Record Date | 1 |
| Trading Window | 1 |
| Procedural sub-total | 28 |
| Total | 35 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
35 filings · 7 selected · busiest 2026-08-14
Filing rhythm · the twelve most recent
2026-09-072026-10-01
SelectedProcedural
Filings
35 in the window · 3 earlier on record
-
1 October 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Scrutinizer Report and Voting Results for AGM 2026
AGM/EGM / AGM View filing →
-
29 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 33rd AGM of the Company
AGM/EGM / AGM View filing →
-
28 September 2026 ·
General Update
Intimation on Material transaction by the subsidiaries
Company Update / General View filing →
-
25 September 2026 ·
Closure of Trading Window
Intimation of closure of Trading Window wef October 1, 2026
Insider Trading / SAST / Closure of Trading Window View filing →
-
24 September 2026 ·
Board Meeting Outcome for Board's Approval For Proposed Investments In Material Wholly Owned Subsidiaries
i) Rights Issue by Material Unlisted Subsidiary Companies ii) Investment in Equity shares of wholly owned Material Subsidiaries of the Company
Others / Outcome without intimation View filing →
-
17 September 2026 ·
Presentation Of Investor/Analyst Meeting
Revised Presentation of Investor/Analyst call
Company Update / General View filing →
-
16 September 2026 ·
-
9 September 2026 ·
Newspaper Publication
Newspaper Advertisement for completion of dispatch, of Annual Report FY 2025-26, to Shareholders
Company Update / Newspaper Publication View filing →
-
7 September 2026 ·
Business Responsibility and Sustainability Reporting (BRSR)
BRSR report for the FY 2025-26
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
7 September 2026 ·
Reg. 34 (1) Annual Report.
33rd Annual Report of Fischer Medical Ventures Limited
Others / Reg. 34 (1) Annual Report View filing →
-
7 September 2026 ·
Intimation Of 33Rd AGM Of Fischer Medical Ventures Limited
33rd AGM of Fischer Medical Ventures Limited is scheduled to be held on 29.09.2026 at 11:00 AM IST
AGM/EGM / AGM View filing →
-
7 September 2026 ·
Analyst / Investor Meet - Intimation
Fischer Medical Ventures Limited has informed the exchange on the presentation for the Investor/Analyst call scheduled to be held on 07.09.2026.
Company Update / Analyst / Investor Meet View filing →
-
4 September 2026 ·
Analyst / Investor Meet - Intimation
Fischer Medical Ventures Limited has informed the exchange on the Analyst/Investor Meet scheduled on 07-09-2026.
Company Update / Analyst / Investor Meet View filing →
-
3 September 2026 ·
Record Date For E-Voting At AGM And Dividend
Intimation of Record Date for E-Voting and payment of Dividend to Shareholders
Corp. Action / Record Date View filing →
-
3 September 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting
I)Approval of Appointment of Independed Director II)Approval of AGM Notice & Book Closure III) Reconstitution of Committee
Others / Outcome without intimation View filing →
-
28 August 2026 ·
Press Release / Media Release
Fischer Medical Ventures Ltd informed the exchange on the Press Release titled Time Medical International Ventures launches Next-generation CLARION 64/128- Slice AI-driven CT system at ....
Company Update / Press Release / Media Release View filing →
-
24 August 2026 ·
Press Release / Media Release
Fischer Medical Ventures Limited has informed the exchange on the press release titled "Catanduanes Integrated Digital Healthcare project Awarded to Time Medical Philippines".
Company Update / Press Release / Media Release View filing →
-
18 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shankar Varadharajan & Others
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
18 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shankar Varadharajan & PACs
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
18 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shankar Varadharajan & Others
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
17 August 2026 ·
Allotment
Allotment of equity shares pursuant to conversion of warrants
Company Update / Allotment of Equity Shares View filing →
-
14 August 2026 ·
Allotment
Allotment of equity shares pursuant to conversion of warrants
Company Update / Allotment of Equity Shares View filing →
-
14 August 2026 ·
Financial Results For Q 1 FY 2026-27
Approval of Q 1 financial results for FY 2026-27
Result / Financial Results View filing →
-
14 August 2026 ·
Resignation of Director
Resgination of Independent Directors
Company Update / Resignation of Director View filing →
-
14 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting
Approval of Q 1 financial results FY 2026-27 in alia, considered other matters.
Board Meeting / Outcome of Board Meeting View filing →
-
14 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shankar Varadharajan & PACs
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
13 August 2026 ·
Monitoring Agency Report
Monitoring Agency Report for quarter ended 30th June 2026
Company Update / Monitoring Agency Report View filing →
-
13 August 2026 ·
Allotment
Allotment of equity shares pursuant to conversion of warrants
Company Update / Allotment of Equity Shares View filing →
-
12 August 2026 ·
Allotment
Allotment of Equity shares pursuant to Conversion of warrants.
Company Update / Allotment of Equity Shares View filing →
-
12 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shankar Varadharajan & PACs
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
11 August 2026 ·
Allotment
Allotment of 23,00,000 Equity shares pursuant to conversion of warrants
Company Update / Allotment of Equity Shares View filing →
-
11 August 2026 ·
Newspaper Publication
Newspaper Advt- Special Window for Re-lodgement of Transfer Request for Physical Shares
Company Update / Newspaper Publication View filing →
-
7 August 2026 ·
Board Meeting Intimation for Approval Of Un-Audited Financial Results For Quarter Ended 30Th June 2026.
Fischer Medical Ventures Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve un-audited financial ....
Board Meeting / Board Meeting View filing →
-
31 July 2026 ·
Press Release / Media Release
Time Medical International Ventures (India) Pvt Ltd, a wholly owned subsidiary of Fischer Medical Ventures Limited, announces partnership for Installation of Inter-Op MRI Suite.
Company Update / Press Release / Media Release View filing →
-
30 July 2026 ·
Press Release / Media Release
Fischer Medical Ventures Secures CDSCO Import Approval for Spincare- India's First Regulatory Clearance for a Portable Electrospun Wound Care System.
Company Update / Press Release / Media Release View filing →
RSS feed for Fischer Medical Ventures Ltd · the 50 most recent filings